from the fast evolving discipline of cancer therapeutics, comprehending the intricate mechanisms of Antibody-Drug Conjugates (ADCs) is crucial for developing successful therapies. Among the most promising approaches is using in vitro bystander result assays, which Participate in a pivotal position in improving therapeutic efficacy. These assays, su